Derived system laws that describe the operations at the systems level as components are altered could significantly advance analyses of natural and synthetic myosin performance [14,15], and have particular applications relating to myosin-based diseases such as cardiomyopathy, where muscle tissue growth is affected by individual myosin configuration [16]. This evidence concerns the gene MYH14 and cardiomyopathy.